Coupling of Fcγ receptor I to Fcγ receptor IIb by SRC kinase mediates C-reactive protein impairment of endothelial function (scientific article published on 22 September 2011)

Selective blockade of inhibitory Fcgamma receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells

Q33865201

Immune inhibitory receptors

Q34054933

C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease

Q34311841

C-reactive Protein

Q34344434

The scavenger receptor class B type I adaptor protein PDZK1 maintains endothelial monolayer integrity.

Q34655581

C-reactive protein: risk marker or mediator in atherothrombosis?

Q35775733

Rheumatoid arthritis: a disease associated with accelerated atherogenesis

Q36220303

Exaggerated neointima formation in human C-reactive protein transgenic mice is IgG Fc receptor type I (Fc gamma RI)-dependent.

Q36357402

Insulin resistance, chronic inflammatory state and the link with systemic lupus erythematosus-related coronary disease

Q36655696

Cardiovascular actions of insulin

Q36831533

C-reactive protein inhibits insulin activation of endothelial nitric oxide synthase via the immunoreceptor tyrosine-based inhibition motif of FcgammaRIIB and SHIP-1.

Q37323477

Functional and clinical consequences of Fc receptor polymorphic and copy number variants.

Q37552028

The Src, Syk, and Tec family kinases: distinct types of molecular switches

Q37703668

C-reactive protein: risk factor, biomarker and/or therapeutic target?

Q37729881

FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications.

Q37736263

A full complement of receptors in immune complex diseases

Q39740198

Blood pressure, C-reactive protein, and risk of future cardiovascular events

Q40547246

Src kinase mediates phosphatidylinositol 3-kinase/Akt-dependent rapid endothelial nitric-oxide synthase activation by estrogen

Q40690125

Serum amyloid P component and C-reactive protein opsonize apoptotic cells for phagocytosis through Fcgamma receptors

Q40691926

Is C-reactive protein an independent risk factor for essential hypertension?

Q43630767

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

Q44216708

High density lipoprotein-induced endothelial nitric-oxide synthase activation is mediated by Akt and MAP kinases

Q44269059

The phosphocholine and the polycation-binding sites on rabbit C-reactive protein are structurally and functionally distinct

Q44442945

Ligand-independent activation of vascular endothelial growth factor receptor 2 by fluid shear stress regulates activation of endothelial nitric oxide synthase

Q44534254

Binding and internalization of C-reactive protein by Fcgamma receptors on human aortic endothelial cells mediates biological effects

Q46463135

Impaired endothelial function in C-reactive protein overexpressing mice.

Q46629339

FcgammaRIIB mediates C-reactive protein inhibition of endothelial NO synthase

Q46790570

Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease

Q74232819

C-reactive protein causes downregulation of vascular angiotensin subtype 2 receptors and systolic hypertension in mice

Q79731225

C-reactive protein downregulates endothelial NO synthase and attenuates reendothelialization in vivo in mice

Q80187071

A simple method of isolating mouse aortic endothelial cells

Q80379544

P433

issue

P921

main subject

endothelium

Q111140

P304

page(s)

1132-1140

P577

publication date

2011-09-22

P1433

published in

Circulation Research

Q2599020

P1476

title

Coupling of Fcγ receptor I to Fcγ receptor IIb by SRC kinase mediates C-reactive protein impairment of endothelial function

P478

volume

109

Reverse relations

cites work (P2860)

Q44147232	Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group
Q36635312	C-reactive protein causes insulin resistance in mice through Fcγ receptor IIB-mediated inhibition of skeletal muscle glucose delivery
Q33562207	C-reactive protein promotes atherosclerosis by increasing LDL transcytosis across endothelial cells
Q35289480	C-reactive protein stimulates RAGE expression in human coronary artery endothelial cells in vitro via ROS generation and ERK/NF-κB activation
Q48032584	Elevated vaginal pH in the absence of current vaginal infection, still a challenging obstetrical problem
Q37025640	Endothelial Fcγ Receptor IIB Activation Blunts Insulin Delivery to Skeletal Muscle to Cause Insulin Resistance in Mice.
Q27021449	Fcγ receptors and ligands and cardiovascular disease
Q35568476	IgG receptor FcγRIIB plays a key role in obesity-induced hypertension.
Q37052905	LXRβ/estrogen receptor-α signaling in lipid rafts preserves endothelial integrity
Q30565938	Mutation of the palmitoylation site of estrogen receptor α in vivo reveals tissue-specific roles for membrane versus nuclear actions.
Q24338726	Selective activation of lectin-like oxidized low-density lipoprotein receptor-1 mediates C-reactive protein-evoked endothelial vasodilator dysfunction in coronary arterioles
Q38615380	The biology of the classical Fcγ receptors in non-hematopoietic cells
Q38017950	The role of Fcγ receptors in atherosclerosis

P356	DOI	10.1161/CIRCRESAHA.111.254573
P932	PMC publication ID	3215097
P698	PubMed publication ID	21940940